In more recall news, all lots of the new anemia drug Peginesatide – also known as Omontys – have been recalled because of severe hypersensitivity reactions. Reactions prompt recall
The recently approved product is an injectable drug developed to treat anemia in patients undergoing kidney dialysis.
It took a third warning from the FDA www.fda.gov, but the makers of dietary supplements known as Reumofan Plus and Reumofan Plus Premium issued a recall notice on Feb. 15 after potentially harmful ingredients were found in Reumofan Plus during the FDA’s analysis.
Update from CaseyGerry Pharma Team
Incidents of a rare strain of fungal meningitis and other related infections continue to mount, with at least 363 cases and 28 deaths in 19 states linked to contaminated steroid injections supplied by the New England Compounding Center (NECC), in Framingham, Massachusetts.
